← Back to Search

Cognitive Assessment for Liver Surgery Patients

N/A

Waitlist Available

Led By Timothy Newhook, MD

Research Sponsored by M.D. Anderson Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

* All English-speaking patients undergoing hepatectomy at main campus University of Texas (UT)-MD Anderson Cancer Center who are cognitively able to provide informed consent in the opinion of the attending physician

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 1 year

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing how well electronic neurocognitive tools can screen for mental capability in patients who are undergoing liver surgery. The hope is that these tools will be able to better assess mental impairment.

Who is the study for?

This trial is for English-speaking patients at UT-MD Anderson Cancer Center who are about to have liver surgery and can give informed consent. It's designed to see if they're mentally sharp enough for the procedure.

What is being tested?

The study is testing electronic tools called BrainCheck Cognitive Assessment to screen mental capability in patients before liver surgery, aiming to identify any cognitive impairments more effectively.

What are the potential side effects?

Since this trial involves non-invasive cognitive assessments, there are no direct physical side effects expected from participating in the study.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Average time to complete the BrainCheck battery

Average time to complete the pen and paper assessment

Completion rate of the BrainCheck battery

+5 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Group I (BrainCheck and paper and pen cognitive assessment)Experimental Treatment2 Interventions

Patients receive the BrainCheck cognitive assessment over 15 minutes followed by the paper and pen assessment 2 months prior to surgery and within 2 months after surgery.

Group II: Group II (pen and paper and BrainCheck cognitive assessment)Active Control2 Interventions

Patients receive the paper and pen assessment followed by the BrainCheck cognitive assessment over 15 minutes 2 months prior to surgery and within 2 months after surgery.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

BrainCheck Cognitive Assessment

2020

N/A

~40

Cognitive Assessment

2011

Completed Phase 2

~1420